In silico drug repurposing against SARS-CoV-2 using an integrative transcriptomic profiling approach: Hydrocortisone and Benzhydrocodone as potential drug candidates against COVID-19

COVID-19 pathogenesis is mainly attributed to dysregulated antiviral immune response, the prominent hallmark of COVID-19. As no established drugs are available against SARS-CoV-2 and developing new ones would be a big challenge, repurposing of existing drugs holds promise against COVID-19. Here, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirmohammadi, SeyedehMozhdeh, Kianmehr, Anvarsadat, Sabbaghian, Amir, Mohebbi, Alireza, Shahbazmohammadi, Hamid, Sheykharabi, Mehdi, Bazzi, Zahra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212771/
https://www.ncbi.nlm.nih.gov/pubmed/35718334
http://dx.doi.org/10.1016/j.meegid.2022.105318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212771/
https://www.ncbi.nlm.nih.gov/pubmed/35718334
http://dx.doi.org/10.1016/j.meegid.2022.105318

Ejemplares similares